Broncus Technologies

United States
Plain, Wisconsin, United States, 94043

Company profile

Broncus Technologies company profile

Broncus Technologies is a medical technology company focused on developing minimally-invasive medical devices for emphysema and other lung diseases. Broncus is investigating the Exhale emphysema product line to perform our patented treatment method called Airway Bypass. Airway Bypass could be the first minimally-invasive procedure for the treatment of homogeneous, or diffuse, emphysema, which constitutes the majority of the emphysema patient population. Broncus is currently enrolling patients worldwide in our pivotal EASE Trial investigating a treatment of severe homogeneous emphysema. Broncus is located in Mountain View, CA (San Francisco Bay area). Broncus International is located in Nyon, Switzerland.

Business identity

Contact email
[email protected]
Phone number
+1 650-428-1600
Operating status
Active
Company type
For Profit
Employee range
51-100 employees
Revenue range
$0-$1M
Founded
1997-01-01, Year

Headquarters

Postal code
94043
Country code
US
Continent
North America

Capital profile

Funding and company signals

Funding stage
IPO
Funding rounds
14
Total equity funding
$154.1M
Last funding
Series D / 2021-01-28
Last equity funding
Series D
Investors
31
Lead investors
6
Founders
1
Articles
12
Exited on
2021-09-24

Founders and investors

Founders

Glen French

Lead investors

Ares Life SciencesFountainVest PartnersHBM Healthcare InvestmentsIntuitiveLake Bleu CapitalQiming Venture Partners

Investors

AbingworthBoston ScientificFountainVest PartnersMenlo VenturesQiming Venture Partners